NOWDiagnostics, Inc.
Springdale, Arkansas, United States · Biotechnology, Healthcare, Health Care
NOWDiagnostics (NOWDx) develops and manufactures 'Touch to Test' over-the-counter and point of care diagnostic tests that yield results in minutes. It is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.
Key facts
- Headquarters
- Springdale, Arkansas, United States
- Employees
- 37
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Private
- Website
- nowdx.com
- Company page
Recent activity at NOWDiagnostics, Inc.
- : NOWDiagnostics Appoints Lisa A. Nibauer as Chief Executive Officer
- : NOWDiagnostics Launches First To Know® Syphilis Test Through TakeMeHome Initiative to Combat Syphilis Epidemic
- : NOWDx Partners with NASTAD and BHOC for the TakeMeHome Initiative
- : NOWDiagnostics and Labcorp Collaborate to Expand Access to FDA-Authorized Syphilis Test in the U.S.
- : NOWDiagnostics, Inc. raised $22.5 million in Series B funding led by DigitalDx Ventures with Labcorp Venture Fund and Kompass Kapital Management participating
- : NOWDiagnostics Appoints Jody Douglas Berry as Chief Scientific Officer
- : NOWDiagnostics, Inc.
- : NOWDiagnostics, Inc.
- : NOWDiagnostics, Inc.
NOWDiagnostics, Inc. funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2024 | Series B | $22.5M |
| Dec 2019 | Venture | $19.0M |
| Jul 2018 | Venture | $13.3M |
| Jul 2016 | Venture | $10.9M |
Leadership
- Jeff Montie, Director
- Charles Farkas, Director
- Doug Degn, Director
- John Harley, Director
- Gerald Gallwas, Director
- Jeremy Wilson, Director
- Kevin Clark, Executive Officer, Director
- Jeff Montie, Director
- John Harley, Director
- Gerald Galwas, Director
- Doug Degn, Director
- Clete Brewer, Director, Promoter
Verified email and direct lines for NOWDiagnostics, Inc.’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
NOWDiagnostics, Inc. files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
NOWDiagnostics, Inc. in the news
- NOWDx Submits De Novo Classification Request to the FDA for Its First to Know ™ Over-the-Counter Syphilis Test - BioSpace (Jan 09, 2024)
- Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use - Business Wire (Aug 16, 2024)
- NOWDiagnostics Secures $22.5 Million in Series B Funding - Business Wire (Jul 09, 2024)
Companies similar to NOWDiagnostics, Inc.
- CurvaFix · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- Tenon Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- Shape Memory Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- JenaValve · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- SynerFuse, Inc. · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
About NOWDiagnostics, Inc.: questions and answers
What does NOWDiagnostics, Inc. do?
NOWDiagnostics (NOWDx) develops and manufactures 'Touch to Test' over-the-counter and point of care diagnostic tests that yield results in minutes. It is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.
Where is NOWDiagnostics, Inc. headquartered?
NOWDiagnostics, Inc. is headquartered in Springdale, Arkansas, United States.
How many employees does NOWDiagnostics, Inc. have?
NOWDiagnostics, Inc. has about 37 employees.
Has NOWDiagnostics, Inc. raised funding?
Yes. Fundz has recorded 4 funding events for NOWDiagnostics, Inc.. The most recent, Series B of $22.5M, was in Jul 2024.
What is the latest news on NOWDiagnostics, Inc.?
On May 28, 2026, NOWDiagnostics Appoints Lisa A. Nibauer as Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy